These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 8011004

  • 1. New classes of antimuscarinic agents endowed with selective antispasmodic properties. 1-Arylsulfonyl pyrrolidin-2-ones and 2-thiones, 1-arylsulfonyl piperidin-2-ones and 2-thiones and 1-arylsulfonyl hexahydro-2H-azepin-2-one.
    Toja E, Parini C, Bonetti C, Hunt P, Fortin M, Barzaghi F, Cesana R, Maggioni A, Nencioni A, Galliani G.
    Arzneimittelforschung; 1994 Apr; 44(4):501-9. PubMed ID: 8011004
    [Abstract] [Full Text] [Related]

  • 2. Cimetropium: characterization of antimuscarinic and spasmolytic properties.
    Schiavone A, Schiavi GB, De Conti L, Micheletti R, Sagrada A, Hammer R, Giachetti A.
    Arzneimittelforschung; 1985 Apr; 35(5):796-9. PubMed ID: 4026901
    [Abstract] [Full Text] [Related]

  • 3. Antispasmodic action of propinox on the isolated human gallbladder: possible mechanism of action.
    Baistrocchi RL, Orti E, de los Santos AR, Di Girolamo G, Marti ML, Pico JC.
    Acta Physiol Pharmacol Ther Latinoam; 1999 Apr; 49(3):161-9. PubMed ID: 10797855
    [Abstract] [Full Text] [Related]

  • 4. Effect of cimetropium bromide and other antispasmodic compounds on in vitro guinea-pig gallbladder.
    Scarpignato C, Cartellá A, Zappia L.
    Methods Find Exp Clin Pharmacol; 1989 May; 11(5):323-9. PubMed ID: 2755278
    [Abstract] [Full Text] [Related]

  • 5. Cimetropium bromide, a new antispasmodic compound: pharmacology and therapeutic perspectives.
    Scarpignato C, Bianchi Porro G.
    Int J Clin Pharmacol Res; 1985 May; 5(6):467-77. PubMed ID: 3912339
    [Abstract] [Full Text] [Related]

  • 6. Assessment of potential selectivity of antispasmodics for the various sections of the gastrointestinal tract of the rat as a guideline for their clinical use.
    Maggi CA, Meli A.
    Arch Int Pharmacodyn Ther; 1983 Apr; 262(2):221-31. PubMed ID: 6135399
    [Abstract] [Full Text] [Related]

  • 7. Comparison of in vitro actions with behavioral effects of antimuscarinic agents.
    Witkin JM, Gordon RK, Chiang PK.
    J Pharmacol Exp Ther; 1987 Sep; 242(3):796-803. PubMed ID: 3498817
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological properties of the novel antimuscarinic agent 4-[2-(1,2-benzisoxazol-3-yl)-2-(hexahydro-1H-azepin-1-yl)a cetoxy]-1-et hyl-1- methylpiperidinium iodide.
    Kawashima K, Yoshida N, Kadokawa T.
    Arzneimittelforschung; 1986 Jun; 36(6):927-35. PubMed ID: 3741526
    [Abstract] [Full Text] [Related]

  • 9. [The M-receptor antagonism of a new cholinolytic compounds TBBB in comparison with hyocine bromide (HBB) and atropine].
    Dai DZ, Lin J, Wang LY, Zhang DL, Huang J, Xing WF.
    Yao Xue Xue Bao; 1986 Nov; 21(11):853-6. PubMed ID: 3591321
    [No Abstract] [Full Text] [Related]

  • 10. Urinary bladder-selective action of the new antimuscarinic compound vamicamide.
    Oyasu H, Yamamoto T, Sato N, Sawada T, Ozaki R, Mukai T, Ozaki T, Nishii M, Sato H, Fujiwara T.
    Arzneimittelforschung; 1994 Nov; 44(11):1242-9. PubMed ID: 7848339
    [Abstract] [Full Text] [Related]

  • 11. Effects of terflavoxate on stimulated contractions of urinary bladder in vitro.
    Testa R, Guarneri L, Bernasconi P, Angelico P, Ibba M, Poggesi E, Meli A.
    Arzneimittelforschung; 1993 Feb; 43(2):122-8. PubMed ID: 8384453
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of alkylating agents on the multiple muscarinic receptor subtypes linked to activation of phospholipase C by carbachol in rat brain cortical membranes.
    Sallés J, Wallace MA, Fain JN.
    J Pharmacol Exp Ther; 1993 Feb; 264(2):521-9. PubMed ID: 8437104
    [Abstract] [Full Text] [Related]

  • 13. [Comparison of pharmacological effects of L- and DL-n-butyl-scopolamine in rat uterus].
    Liao WJ, Qu ZW, Zhang JT.
    Yao Xue Xue Bao; 1994 Feb; 29(1):24-7. PubMed ID: 8036897
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological properties of (2R)-N-[1-(6-aminopyridin-2-ylmethyl)piperidin-4-yl]-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: a novel mucarinic antagonist with M(2)-sparing antagonistic activity.
    Hirose H, Aoki I, Kimura T, Fujikawa T, Numazawa T, Sasaki K, Sato A, Hasegawa T, Nishikibe M, Mitsuya M, Ohtake N, Mase T, Noguchi K.
    J Pharmacol Exp Ther; 2001 May; 297(2):790-7. PubMed ID: 11303071
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological evidence for cardiac muscarinic receptor subtypes.
    Chassaing C, Dureng G, Baissat J, Duchêne-Marullaz P.
    Life Sci; 1984 Oct 22; 35(17):1739-45. PubMed ID: 6548282
    [Abstract] [Full Text] [Related]

  • 16. Characterization of antimuscarinic effect of cimetropium bromide in guinea pig ileum.
    Saitoh N, Nishio H, Takeuchi T, Hata F.
    J Smooth Muscle Res; 1997 Feb 22; 33(1):1-9. PubMed ID: 9127842
    [Abstract] [Full Text] [Related]

  • 17. Cardioselective antimuscarinic action of a dopamine receptor agonist, N,N-dipropyl-2-aminotetralin (TL-68).
    Sahin I, Ilhan M.
    Arch Int Pharmacodyn Ther; 1987 Dec 22; 290(2):185-92. PubMed ID: 3446046
    [Abstract] [Full Text] [Related]

  • 18. The conversion of 2-chloroalkylamine analogues of oxotremorine to aziridinium ions and their interactions with muscarinic receptors in the guinea pig ileum.
    Ringdahl B, Resul B, Ehlert FJ, Jenden DJ, Dahlbom R.
    Mol Pharmacol; 1984 Sep 22; 26(2):170-9. PubMed ID: 6332977
    [Abstract] [Full Text] [Related]

  • 19. Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part 1: Antimuscarinic and spasmolytic effects.
    Zwagemakers JM, Claassen V.
    Arzneimittelforschung; 1980 Sep 22; 30(9):1517-26. PubMed ID: 7193020
    [Abstract] [Full Text] [Related]

  • 20. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
    Kitano Y, Makino M, Usui C, Takasuna K, Kasai Y, Hirohashi M, Tamura K, Takayama S, Kojima H, Iizuka H.
    Arzneimittelforschung; 1994 Feb 22; 44(2A):199-210. PubMed ID: 8018090
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.